Mark Schulte, M.D.
NPI 1093973471 · Rheumatology Physician · West Seneca, NY
Enrolled with Medicare as Practitioner - Rheumatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1093973471
- Entity type
- Individual
- Primary specialty
- Rheumatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 57.008831 (OH)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
943 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 321 | $121 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 229 | $121 |
| Administration of Chemotherapy Into Vein, Each Additional Hour96415 | 147 | $26 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 122 | $15 |
| Aspiration And/Or Injection of Fluid From Large Joint20610 | 48 | $55 |
| Injection of Drug Or Substance Under Skin Or Into Muscle |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 41 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Methotrexate Sodiumbrand: Methotrexate | 500 | 105 |
| Prednisone | 344 | 94 |
| Duloxetine Hcl | 192 | 53 |
| Hydroxychloroquine Sulfate | 178 | 46 |
| Gabapentin | 163 | 37 |
| Celecoxib | 160 | 44 |
| Hydrocodone/Acetaminophen |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$797 across 30 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-06-02
- Last updated
- 2011-12-12
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.